DEBT CONVERSION AGREEMENTDebt Conversion Agreement • October 5th, 2021 • 180 Life Sciences Corp. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 5th, 2021 Company Industry JurisdictionThis Debt Conversion Agreement (this “Agreement”) dated September [ ], 2021 and effective September 30, 2021 (the “Effective Date”), is by and between, 180 Life Sciences Corp., a Delaware corporation (the “Company”), Dr. Lawrence Steinman (“Steinman”) and Sir Marc Feldmann (“Feldmann”, and collectively with Steinman, the “Creditors”), individuals, each a “Party” and collectively the “Parties.”